Summary: Volteface highlights the upcoming Breaking Convention 2017: 4th Psychedelic Research Conference in London, England, where psychedelic researchers, advocates, and attendees from around the world are gathering to share and explore new research into the therapeutic benefits of psychedelics. “According to a psychiatrist and MDMA researcher, the top three scientific ‘must-see’s’ are: Neuroscientist Dr Robin Carhart-Harris of Imperial College’s Psychedelic Research Programme, Rick Doblin of the Multidisciplinary Association for Psychedelic Studies’ (MAPS) whose Phase 3 trials of MDMA as a treatment for PTSD are set to start in the USA later this year, and Heffter Research Institute founder Dave Nichols, who will be joining David Luke and David King for a session on ‘DMT in the Human,’” explains Rosalind Stone of Volteface.